- Home
- All Stock List
- BSE
- Fredun Pharmaceuticals Ltd Share Price
668.55
-13.80 (-2.02%)
-
Underperforms Index
-6.8%
Return (1Y)
Underperformed BSE Sensex by 11.91%
-
More Volatile
3.02%
Standard Deviation (1Y)
Higher than BSE Sensex by 2.14%
-
Not so consistent
4/12
Months
underperformed BSE Sensex
-
AxisDirect View
No View
1,024
635
News & Announcements
-
Fredun Pharmaceuticals announces its foray into large animal veterinary segment
12 - Mar - 2025 12:00 | 19 days ago
Fredun Pharmaceuticals announced its foray into the large animal veterinary segment, under the FREOSSI Large Animals brand with the launch of targeted products Freossi Tone+ and Freossi Power. FREOSSI has a strong & existing reputation in companion animal care, hence this will provide a foundation of trust and reliability when expanding into large animal products.
These new products have scientific & clinical evidence and are developed with the expertise of veterinary professionals in animal health. They specifically are designed to address key health challenges faced by livestock owners including lactation issues, quality of milk, joint stiffness, and mobility concerns.
Commenting on the Development, Fredun Medhora, Managing Director, said: “Our foray into the large animal healthcare space is a strategic step in expanding Fredun Pharma's presence in veterinary healthcare, while reinforcing our commitment to innovation and quality. With Freossi Tone + and Freossi Power, we are addressing key challenges faced by livestock owners while promoting the overall advancement of animal health. This marks an important milestone as we work towards offering specialized solutions across the broader veterinary spectrum.”
Powered by Capital Market - Live News
-
Fredun Pharmaceuticals standalone net profit rises 26.30% in the December 2024 quarter
05 - Feb - 2025 12:00 | 54 days ago
Net profit of Fredun Pharmaceuticals rose 26.30% to Rs 5.33 crore in the quarter ended December 2024 as against Rs 4.22 crore during the previous quarter ended December 2023. Sales rose 17.53% to Rs 101.84 crore in the quarter ended December 2024 as against Rs 86.65 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 101.84 86.65 18 OPM % 12.98 12.14 - PBDT 8.22 6.75 22 PBT 7.13 5.76 24 NP 5.33 4.22 26 Powered by Capital Market - Live News
-
Fredun Pharmaceuticals to table results
67 days ago
-
Fredun Pharmaceuticals standalone net profit rises 26.30% in the December 2024 quarter
05 - Feb - 2025 12:00 | 54 days ago
Net profit of Fredun Pharmaceuticals rose 26.30% to Rs 5.33 crore in the quarter ended December 2024 as against Rs 4.22 crore during the previous quarter ended December 2023. Sales rose 17.53% to Rs 101.84 crore in the quarter ended December 2024 as against Rs 86.65 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 101.84 86.65 18 OPM % 12.98 12.14 - PBDT 8.22 6.75 22 PBT 7.13 5.76 24 NP 5.33 4.22 26 Powered by Capital Market - Live News
-
Fredun Pharmaceuticals to table results
67 days ago
-
Fredun Pharmaceuticals standalone net profit rises 8.38% in the September 2024 quarter
28 - Oct - 2024 12:00 | 154 days ago
Net profit of Fredun Pharmaceuticals rose 8.38% to Rs 4.27 crore in the quarter ended September 2024 as against Rs 3.94 crore during the previous quarter ended September 2023. Sales rose 31.19% to Rs 106.89 crore in the quarter ended September 2024 as against Rs 81.48 crore during the previous quarter ended September 2023.
Particulars Quarter Ended Sep. 2024 Sep. 2023 % Var. Sales 106.89 81.48 31 OPM % 13.04 11.79 - PBDT 8.63 6.71 29 PBT 7.57 5.77 31 NP 4.27 3.94 8 Powered by Capital Market - Live News
-
Fredun Pharmaceuticals announces its foray into large animal veterinary segment
12 - Mar - 2025 12:00 | 19 days ago
Fredun Pharmaceuticals announced its foray into the large animal veterinary segment, under the FREOSSI Large Animals brand with the launch of targeted products Freossi Tone+ and Freossi Power. FREOSSI has a strong & existing reputation in companion animal care, hence this will provide a foundation of trust and reliability when expanding into large animal products.
These new products have scientific & clinical evidence and are developed with the expertise of veterinary professionals in animal health. They specifically are designed to address key health challenges faced by livestock owners including lactation issues, quality of milk, joint stiffness, and mobility concerns.
Commenting on the Development, Fredun Medhora, Managing Director, said: “Our foray into the large animal healthcare space is a strategic step in expanding Fredun Pharma's presence in veterinary healthcare, while reinforcing our commitment to innovation and quality. With Freossi Tone + and Freossi Power, we are addressing key challenges faced by livestock owners while promoting the overall advancement of animal health. This marks an important milestone as we work towards offering specialized solutions across the broader veterinary spectrum.”
Powered by Capital Market - Live News
-
Fredun Pharmaceuticals standalone net profit rises 26.30% in the December 2024 quarter
05 - Feb - 2025 12:00 | 54 days ago
Net profit of Fredun Pharmaceuticals rose 26.30% to Rs 5.33 crore in the quarter ended December 2024 as against Rs 4.22 crore during the previous quarter ended December 2023. Sales rose 17.53% to Rs 101.84 crore in the quarter ended December 2024 as against Rs 86.65 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 101.84 86.65 18 OPM % 12.98 12.14 - PBDT 8.22 6.75 22 PBT 7.13 5.76 24 NP 5.33 4.22 26 Powered by Capital Market - Live News
-
Fredun Pharmaceuticals to table results
67 days ago
-
Fredun Pharmaceuticals standalone net profit rises 8.38% in the September 2024 quarter
28 - Oct - 2024 12:00 | 154 days ago
Net profit of Fredun Pharmaceuticals rose 8.38% to Rs 4.27 crore in the quarter ended September 2024 as against Rs 3.94 crore during the previous quarter ended September 2023. Sales rose 31.19% to Rs 106.89 crore in the quarter ended September 2024 as against Rs 81.48 crore during the previous quarter ended September 2023.
Particulars Quarter Ended Sep. 2024 Sep. 2023 % Var. Sales 106.89 81.48 31 OPM % 13.04 11.79 - PBDT 8.63 6.71 29 PBT 7.57 5.77 31 NP 4.27 3.94 8 Powered by Capital Market - Live News
-
Fredun Pharmaceuticals announces its foray into large animal veterinary segment
12 - Mar - 2025 12:00 | 19 days ago
Fredun Pharmaceuticals announced its foray into the large animal veterinary segment, under the FREOSSI Large Animals brand with the launch of targeted products Freossi Tone+ and Freossi Power. FREOSSI has a strong & existing reputation in companion animal care, hence this will provide a foundation of trust and reliability when expanding into large animal products.
These new products have scientific & clinical evidence and are developed with the expertise of veterinary professionals in animal health. They specifically are designed to address key health challenges faced by livestock owners including lactation issues, quality of milk, joint stiffness, and mobility concerns.
Commenting on the Development, Fredun Medhora, Managing Director, said: “Our foray into the large animal healthcare space is a strategic step in expanding Fredun Pharma's presence in veterinary healthcare, while reinforcing our commitment to innovation and quality. With Freossi Tone + and Freossi Power, we are addressing key challenges faced by livestock owners while promoting the overall advancement of animal health. This marks an important milestone as we work towards offering specialized solutions across the broader veterinary spectrum.”
Powered by Capital Market - Live News
-
Fredun Pharmaceuticals standalone net profit rises 26.30% in the December 2024 quarter
05 - Feb - 2025 12:00 | 54 days ago
Net profit of Fredun Pharmaceuticals rose 26.30% to Rs 5.33 crore in the quarter ended December 2024 as against Rs 4.22 crore during the previous quarter ended December 2023. Sales rose 17.53% to Rs 101.84 crore in the quarter ended December 2024 as against Rs 86.65 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 101.84 86.65 18 OPM % 12.98 12.14 - PBDT 8.22 6.75 22 PBT 7.13 5.76 24 NP 5.33 4.22 26 Powered by Capital Market - Live News
-
Fredun Pharmaceuticals to table results
67 days ago
-
Fredun Pharmaceuticals standalone net profit rises 26.30% in the December 2024 quarter
05 - Feb - 2025 12:00 | 54 days ago
Net profit of Fredun Pharmaceuticals rose 26.30% to Rs 5.33 crore in the quarter ended December 2024 as against Rs 4.22 crore during the previous quarter ended December 2023. Sales rose 17.53% to Rs 101.84 crore in the quarter ended December 2024 as against Rs 86.65 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 101.84 86.65 18 OPM % 12.98 12.14 - PBDT 8.22 6.75 22 PBT 7.13 5.76 24 NP 5.33 4.22 26 Powered by Capital Market - Live News
-
Fredun Pharmaceuticals to table results
67 days ago
-
Fredun Pharmaceuticals standalone net profit rises 8.38% in the September 2024 quarter
28 - Oct - 2024 12:00 | 154 days ago
Net profit of Fredun Pharmaceuticals rose 8.38% to Rs 4.27 crore in the quarter ended September 2024 as against Rs 3.94 crore during the previous quarter ended September 2023. Sales rose 31.19% to Rs 106.89 crore in the quarter ended September 2024 as against Rs 81.48 crore during the previous quarter ended September 2023.
Particulars Quarter Ended Sep. 2024 Sep. 2023 % Var. Sales 106.89 81.48 31 OPM % 13.04 11.79 - PBDT 8.63 6.71 29 PBT 7.57 5.77 31 NP 4.27 3.94 8 Powered by Capital Market - Live News
Stock Trivia
Fredun Pharmaceuticals Ltd is trading very close to its 52 Week Low
Fredun Pharmaceuticals Ltd is trading very close to its 52 Week Low
Fredun Pharmaceuticals Ltd is trading very close to its 52 Week Low
Fredun Pharmaceuticals Ltd is trading very close to its 52 Week Low
Fredun Pharmaceuticals Ltd is trading very close to its 52 Week Low
